This week in gene and cell therapy - 9 March 2018

Gene and cell therapy headlines 5 - 9 March

New xCas9 variant has higher specficity and broader PAM compatibility

Oxford based Nightstart to launch phase III clinical trial of gene therapy for choroideremia

MeirGTx recevies EMA PRIME designation for treatment of achromatopsia

AbbVie and Voyager Therapeutics to collaborate on gene therapy for Alzheimer's disease

FDA sets out path for stem cell therapies